Table: Garna Biosciences -Q1 group results

Carna Biosciences

09/05/2025 08:02

May 9 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2025        Mar 31, 2024       Dec 31, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            143 mln             180 mln           722 mln     
                 (-20.7 pct)         (-20.3 pct)       (+13.5 pct)   
  Operating     loss 497 mln        loss 416 mln        loss 2.13    
  Recurring     loss 498 mln        loss 394 mln        loss 2.14    
  Net           loss 499 mln        loss 398 mln        loss 2.15    
  EPS          loss 26.13 yen      loss 23.27 yen    loss 112.46 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T